تحلیل اختیاری محصول
با اجازه شما، از تحلیلهای محدود و حریمخصوصیمحور استفاده میکنیم تا مسیرهای پژوهشی مؤثر را بشناسیم. از ردیاب تبلیغاتی یا بازپخش نشست استفاده نمیکنیم. این انتخاب را میتوانید در تنظیمات تغییر دهید. بخوانید سیاست حفظ حریم خصوصی.
CME Group Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $109.6B | |
|---|---|---|
| P/E (forward) | 23.5x |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $4.69B | $5.02B | $5.58B | $6.13B | $6.52B | +8.6% |
| Gross profit | $3.85B | $4.27B | $4.75B | $5.28B | $5.61B | +9.9% |
| Operating income | $3.54B | $3.65B | $4.31B | $4.70B | $5.50B | +11.7% |
| Net income | $2.64B | $2.69B | $3.23B | $3.53B | $4.07B | +11.5% |
| EPS (diluted) | $7.29 | $7.40 | $8.86 | $9.67 | $11.16 | +11.2% |
| EBITDA | $3.93B | $4.02B | $4.67B | $5.04B | $5.83B | +10.4% |
| R&D | — | — | — | — | — | — |
| SG&A | $151.7M | $137.4M | $144.4M | $132.7M | $150.5M | -0.2% |
Recent company headlines from major financial publishers.
Prolonged macroeconomic uncertainty, fluctuating interest rates, and geopolitical shifts drive record hedging activity and volume across CME's product suite. The company pushes through pricing increases uninhibited, scaling margins further and driving low-double-digit EPS growth.
CME Group benefits from near-monopoly network effects in interest rate, energy, and agricultural derivatives. Its vertically integrated clearinghouse acts as a massive competitive barrier. As a mature compounder, it generates extraordinary margins and massive free cash flow.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 7.1% | $313 | $347 | $389 | $444 | $457 |
| 8.1% | $261 | $285 | $313 | $347 | $389 |
| 9.1% | $224 | $241 | $261 | $285 | $313 |
| 10.1% | $196 | $209 | $224 | $241 | $261 |
| 11.1% | $175 | $185 | $196 | $209 | $224 |
Upcoming earnings date and setup when available.
رتبهای که نسخهٔ پژوهشی منتشرشدهٔ هر ماه داشت. رتبه قیمت در تاریخ تحلیل را با ارزش منصفانه مقایسه میکند و سابقهای از درستی یا نادرستی ارزیابی نیست.
| سال | دی | بهمن | اسفند | فروردین | اردیبهشت | خرداد | تیر | مرداد | شهریور | مهر | آبان | آذر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |